Tag Archives: This

AstraZeneca's Imfinzi fails another phase 3 trial, this time in head and neck cancer

AstraZeneca is still stinging from Imfinzi’s combo flop in non-small cell lung cancer, but it’s already staring down another defeat. On Friday, the British drugmaker said the immuno-oncology drug had failed to show it could extend the lives of patients with recurrent or metastatic head and neck cancer whose disease has worsened after chemo. The… Read More »

Medical News Today: This form of brain training may help treat severe schizophrenia

New research has revealed that targeted cognitive training can successfully reduce cognitive impairment in treatment-resistant schizophrenia. Altering certain neural pathways may improve cognitive ability in people with treatment-resistant schizophrenia. Schizophrenia is one of the 15 leading causes of disability globally. In the United States, this condition affects more than 3 million people. Symptoms of schizophrenia… Read More »